Absence of association between serum homocysteine levels and coronary artery disease in south Indian males

Indian Heart Journal

Volumn 53, Issue 1, 2001, Pages 44-47

  Deepa, R ^b   Velmurugan, K ^b   Saravanan, G ^b   Karkuzhali, K ^b   Dwarakanath, V ^b   Mohan, V ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b NONE

Author keywords

Coronary disease; Hyperhomocysteinemia; Risk factors

Indexed keywords

HOMOCYSTEINE;

ARTICLE; BLOOD; CAUCASIAN; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; ETHNOLOGY; GENETICS; HUMAN; INDIA; MALE; MIDDLE AGED;

CORONARY DISEASE; DIABETIC ANGIOPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HOMOCYSTEINE; HUMANS; INDIA; MALE; MIDDLE AGED;

EID: 0035223194     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Moghadasian MH, McManus BM, Frohlich JJ. Homocysteine and coronary artery disease. Arch Intern Med 1997; 157: 2301-2307
2. Ueland PM. Homocysteine species as components of plasma redox thiol status. Clin Chem 1995; 41: 340-342
3. Murphy-Chutorian D, Alderman EL. The case that hyperhomocysteinemia is a risk factor for coronary artery disease. Am J Cardiol 1994; 73: 705-706
4. Clarke R, Daly, L, Robinson K, Naughten E, Cahalene S, Fowler B, et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 2324: 1149-1155
5. Guba SC, Fink LM, Fonseca V. Hyperhomocysteinemia - An emerging and important risk factor for thromboembolic and cardiovascular disease. Am J Clin Pathol 1996; 106: 709-722
6. Okada E, Oida K, Tada H, Asazuma K, Eguchi K, Tohda G et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 1999; 22: 484-490
7. Rasmussen K, Moller J, Lyngbak M, Pedersen AMH, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylamalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996; 42: 630-638
8. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms and B vitamins: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1998; 98: 204-210
9. 506). Arterioscler Thromb Vasc Biol 1997; 17: 1662-1666
10. Stabler SP, Marcel PD, Podell ER, Allen RH, Savage DG, Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by gas chromatography - mass spectrophotometry. J Clin Invest 1988; 81: 466-474
11. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylamalonic acid and total homocysteine determinations for diagnosing cobalamin, choline riboflavin and troxerutin in atherosclerosis. Atherosclerosis 1989; 88L: 143-151
12. Balarajan R. Ethnic differences in mortality from ischaemic heart disease in England and Wales. BMJ 1991; 302: 560-564
13. Enas EA, Mehta JL. Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention and treatment. Clin Cardiol 1995; 18: 131-135
14. Bhatnagar D, Anand IS, Durrington PN, Patel DJ, Wander GS, Mackness MI, et al. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet 1995; 345: 405-409
15. Mohan V, Shanthi RS, Deepa R, Anjana M, Premalatha G, Sastry NG, et al. Intra-urban differences in the prevalence of the metabolic syndrome in southern India - The Chennai Urban Population Study (CUPS). Diabet Med 2000 (in press).
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med 1998; 15: 539-553
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
18. Joint National Committee on Detection. Evaluation and Treatment of high blood pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of high blood pressure (JNC-V). Arch Intern Med 1993; 153: 154-183
19. Chambers JC, Obeid OA, Refsum H, Keland P, Hackett D, Hooper J, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000; 355: 523-527
20. Hughes K, Ong CN. Homocysteine, folate, vitamin B12 and cardiovascular risk in Indians. Malays and Chinese in Singapore. J Epidemiol Commun Health 2000; 64: 31-34
21. Chacko KA. Plasma homocysteine levels in patients with coronary heart disease. Indian Heart J 1998; 50: 295-299
22. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-881
23. Alfthan G, Pekkanen J, Jauhainen M, PitKaniemi J, Karonen M, Tuotmilento J, et al. Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994; 106: 9-19
24. Fallon UB, Ben-Shlomo Y, Elwood P, Ubbink JB, Smith GD. Homocysteine and coronary heart disease in the Caerphilly cohort: a 10-year follow-up. Heart 2001; 85: 153-158
25. Danesh J, Whincup P, Walker M, Lennon L, Thompson A, Appleby P et al. Low-grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199-204
26. Das S, Reynolds T, Patnaik A, Rais N, Fink LM, Fonseca VA. Plasma homocysteine concentrations in type II diabetic patients in India: Relationship to body weight. J Diabetes Complications 1999; 13: 200-203
27. Munshi MN, Stone A, Fink L, Fonseca V. Hyperhomocysteinemia following a methionine load in patients with non-insulin dependent diabetes mellitus and macrovascular disease. Metabolism 1996; 45: 133-135
28. Hoffman MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, et al. Hyperhomocysteinemia and endothelial dysfunction in IDDM. Diabetes Care 1997; 20: 1880-1886
29. Fonseca V, Mudaliar S, Schmidt B, Fink LM, Kern PA, Henry RR. Plasma homocysteine concentrations are regulated by acute hyperiosulinemia in diabetic but not type II diabetic subjects. Metabolism 1995; 47: 686-689
30. Guthikonda S, Haynes WG. Homocysteine as a novel risk factor for atherosclerosis. Curr Opin Cardiol 1999; 14: 283-291
31. Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WL, Phillipsum BE, et al. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998; 338: 1009-1015
32. Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, et al. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetra-hydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 1997; 17: 1157-1162
33. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000; 102: 2479-2483
34. Wilkinson IB, Megson IL, MacCallum T, Rooijmans DF, Johnson SM, Boyd JL, et al. Acute methionine loading does not alter arterial stiffness in humans. J Cardiovasc Pharmacol 2001; 37: 1-5
35. Christen WG, Ridker PM. Blood levels of homocysteine and atherosclerotic vascular disease. Curr Atheroscler Rep 2000; 2: 194-199